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Abstract
Background
Apoptosis is a programme of cell death which does not induce an inflammatory response. Recent
previous research has suggested a correlation between temporomandibular internal derangement and
apoptosis. Fas ligand (FasL) is an apoptosis‐inducing factor, known to trigger apoptosis through distinct
signal pathways. This study aims to examine, by immunohistochemistry, the expression of FasL in
temporomandibular joint (TMJ) articular discs of patients with anterior disc displacement with reduction
(ADDwR) and without reduction (ADDwoR) in patients with and without osteoarthrosis (OA).
Methods
Forty‐two (n = 42) TMJ articular discs were divided into two cut‐offs: (i) 8 control, 17 ADDwR, 17
ADDwoR, and (ii) without OA (n = 25) and with OA (n = 17). The area of immunostaining was compared
statistically between groups (P < 0.05).
Results
Statistically significant differences were found in the expression of FasL in TMJ discs between the three
groups (P = 0.001). ADDwR presented significant higher FasL expression when compared with ADDwoR
(P < 0.001). Significant higher FasL expression was observed in the group without OA (P = 0.001). All
patients without OA presented ADDwR, while all the patients with OA presented ADDwoR.
Conclusion
A higher area of in situ immunostaining of FasL was found in temporomandibular discs with reduction,
which is the less severe condition. Moreover, a reduced expression of FasL in the discs of patients with
osteoarthrosis was found, suggesting that some aspects of apoptosis might underlie the progression of
TMJ disorders.

Introduction
Disc derangement is defined as a malpositioning of the articular disc in relation to the condyle and
eminence. The two most common types of internal derangement (ID) are anterior disc displacement
with (ADDwR) and without (ADDwoR) reduction 1-4.
Anterior disc displacement with reduction (ADDwR) is typically defined as a condition in which the
articular disc of the temporomandibular joint (TMJ) is displaced while the mouth is closed and the teeth
are in contact with maximal occlusion and slide into its normal functional position as the jaw open 5, 6.
In ADDwoR, the condyle is unable to slide or snap back underneath the disc. The displaced disc thus
does not reduce to its position on top of the condyle during the opening movement 5, 6.

Clinically, TMJ with mild ID is characterized by disc displacement with or without osseous remodelling,
while severe derangement includes disc or attachment perforations, osseous remodelling and
osteoarthritic changes 7.
Temporomandibular joint ID results from an imbalance between anabolic and catabolic processes,
predominantly controlled by fibrochondrocytes, and is characterized by progressive degradation of the
extracellular matrix of the articular disc 8-10.
Disc displacement is associated with degenerative tissue changes, and it is considered to be a risk factor
for osteoarthrosis (OA) development with abnormal remodelling of the condyle and mandibular fossa;
however, the underlying mechanisms remain unclear 11-20.
Under normal physiological conditions, a balance exists in synovial joints between tissue breakdown and
repair. When the balance is disturbed by a biomechanical or inflammatory insult, the discal
fibrocartilaginous remodelling system may fail, resulting in accelerated tissue breakdown 17. In TMJ
diseases, the synovium and articular cartilage produce several mediators that have the potential to
induce apoptosis 21. Discal fibrochondrocytes are the only cells that produce and maintain the disc
extracellular matrix. Thus, changes in fibrochondrocyte survival (due to cell proliferation, apoptosis, and
other forms of cell death) induced by endogenous mediators may be of pathogenic significance in the
development of articular disc degradation 17, 18.
Previous research has demonstrated a correlation between TMJ ID and apoptosis 22-28. Apoptosis is a
physiopathological process implicated in various aspects of mammalian development, including
embryogenesis, normal tissue turnover and homoeostasis, and also as a protection mechanism in
immune reactions and diseases 22, 29. It can be triggered either by a mitochondrion‐dependent intrinsic
pathway or via a cell surface death receptor–mediated extrinsic pathway. Fas ligand (FasL, also called
CD95L), tumour necrosis factor (TNF)‐α and TNF‐related apoptosis–inducing ligand (TRAIL) are common
apoptosis‐inducing factors, known to trigger apoptosis through distinct signal pathways 30, 29, 31-35.
Fas ligand is a cell membrane–associated factor that induces apoptotic cell death and is related to
various aspects of immune system, including cell‐mediated cytotoxicity and self‐tolerance. FasL seems
to play an immunosuppressive role against not only itself but also exogenous antigens 36, 37. FasL has a
pathogenic involvement in a variety of inflammatory diseases, including hepatitis, graft‐versus‐host
diseases and pulmonary fibrosis 38-43.
In this study, we tested the hypothesis that apoptosis may be involved in the progression of TMJ ID, as
shown by previous research 22-28. Therefore, the present investigation was designed to evaluate, by
immunohistochemistry, the expression of FasL in temporomandibular joint (TMJ) articular discs of
patients with anterior disc displacement with (ADDwR) and without reduction (ADDwoR) in patients
with and without osteoarthrosis (OA), focusing on the role, apoptosis may have in the association
between severity of disc displacement and osteoarthrosis.

Materials and methods
Sample selection

A sample of 42 temporomandibular discs from 29 patients (mean age 32.7 years old, range from 18 to
56 years) was recruited for study from the patient pool at the Evangelico School Hospital, Curitiba, Brazil

(Table 1), as approved by the Ethical Committee on Research at Pontifical Catholic University of Paraná,
according to Resolution 196/96 of the National Health Council and approved under registration number
104. The patients were from the southern region of Brazil. Subjects did not present any of the following
criteria: use of orthodontic appliances; chronic usage of anti‐inflammatory drugs; history of diabetes,
hepatitis, HIV infection; immunosuppressive chemotherapy; history of any disease known to severely
compromise immune function; current pregnancy or lactation; dentofacial deformity; major jaw trauma;
previous TMJ surgery; and previous steroid injection in the TMJ.
Table 1. Baseline clinical characteristics of the study group with and without TMJ dysfunction, associated
with Wilkes Stage
Affected
side
Patient

Gender

1
2
3
4
4
5
5
6
6
7
8
8
9
9
10
10
11
11
12
13
13
14
14
15

Ethnical
group
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian

Diagnosis

Right

F
M
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F

Age
(yrs)
39
27
25
46
46
20
20
41
41
35
32
32
41
41
26
26
28
28
33
36
36
18
18
38

15

III
III
III
III
IV

Osteoarthritic
group
With OA
Without OA
With OA
With OA
With OA
With OA
With OA
Without OA
Without OA
Without OA
Without OA
Without OA
With OA
With OA
Without OA
Without OA
Without OA
Without OA
Without OA
Without OA
Without OA
Without OA
Without OA
With OA

ADDwoR
CFx
ADDwoR
ADDwoR
ADDwoR
ADDwoR
ADDwoR
ADDwR
ADDwR
CH
ADDwR
ADDwR
ADDwoR
ADDwoR
ADDwR
ADDwR
ADDwR
ADDwR
CH
ADDwR
ADDwR
ADDwR
ADDwR
ADDwoR

X
X
X

Caucasian

F

38

ADDwoR

X

IV

With OA

16

Caucasian

F

45

ADDwoR

X

IV

With OA

17

Caucasian

F

23

CH

X

18

Caucasian

F

51

ADDwoR

X

19

Caucasian

F

33

ADDwoR

19

Caucasian

F

33

ADDwoR

X
X
X
X
X
X
X
X
X

Left

X
X
X
X
X
X
X
X
X
X
X
X

X
X

Wilkes
stage
V
V
V
V
V
V
III
III
III
III
V
V
III
III
III
III

Without OA
V

With OA

V

With OA

V

With OA

20

Caucasian

M

22

CFx

X

Without OA

21

Caucasian

F

35

ADDwoR

X

IV

With OA

22

Caucasian

F

22

ADDwR

X

III

Without OA

22

Caucasian

F

22

ADDwR

X

III

Without OA

23

Caucasian

F

24

ADDwR

X

III

Without OA

24

Caucasian

M

18

CFx

25

Caucasian

F

32

CH

26

Caucasian

M

37

CFx

X

27

Caucasian

F

23

ADDwoR

X

27

Caucasian

F

23

ADDwoR

28

Caucasian

F

42

ADDwR

29

Caucasian

F

56

ADDwR

X

Without OA
X

Without OA
Without OA
IV

With OA

IV

With OA

X

III

Without OA

X

III

Without OA

X

ADDwoR, anterior disc displacement without reduction; ADDwR, anterior disc displacement with
reduction; CH, condyle hyperplasia; CFx, condyle fracture; OA, osteoarthrosis.

Subjects completed personal medical history questionnaires and, within a protocol approved by an
Institutional Review Board, signed a consent form after being advised of the nature of the study.
All patients were asked to complete a pain questionnaire, and a clinical examination was performed by
an experienced operating oral and maxillofacial surgeon. The clinical examination consisted of palpation
of the TMJ region, the occurrence of painful opening/closing mouth, and crepitation. The patients were
considered to be affected and treated surgically when presenting painful clinical signs of disc
displacement after unsuccessful non‐surgical treatment for at least 6 months. Regarding complementary
exams, all patients had a panorex. These patients were from the Brazilian public health system;
therefore, a few of them had financial conditions to afford other exams such as computerized
tomography (CT) scan or a TMJ magnetic resonance imaging. Accordingly, the diagnoses were primarily
clinical.
Patients presenting disc displacement with and without reduction were grouped together for analysis.
Out of the control patients, 4 individuals presented condyle fracture (CFx), confirmed by radiographs
and CT scan, which needed to be operated for the fracture reduction and four subjects displayed active
condyle hyperplasia (CH), diagnosed by radiographs, CT scan and scintigraphy, as follows:
•
•
•

Subjects without any signs of disc displacement (control group; n = 8; 8 specimens);
Patients presenting anterior disc displacement with reduction (ADDwR; n = 10; 17 specimens);
Patients presenting anterior disc displacement without reduction (ADDwoR; n = 11; 17
specimens).

Subjects were included in clinical categories according to the presence or absence of disc displacement
and, at a second moment, according to the presence or absence of osteoarthrosis (using Wilkes
classification) 44.
Patients' selection for OA analysis was based on the primary diagnosis of severe TMJ ID. The stages of
TMJ ID were classified into mild, intermediate and severe according to Wilkes classification based on
clinical, surgical and pathological stages 44. Mild internal derangement (Wilkes stage III) is characterized
by simple disc displacement without any morphological alteration of the disc and with or without
osseous shift. The intermediate stage (Wilkes stage IV) is characterized by disc displacement and
morphological deformity and/or osseous remodelling changes. Severe derangement (Wilkes stage V) is
characterized by perforations of the disc attachments and osseous shift and/or osteoarthritic changes
(sclerosis, osteophyte formation, articular surface flattening, depression and/or cystic alterations) 44.
Patients from the control group and those classified as Wilkes III were considered not presenting OA
and patients classified as Wilkes IV or V were included in the OA group, as follows:
•
•

Patients without OA (control group + Wilkes stage III; n = 18; 25 specimens).
Patient with OA (Wilkes stage IV and V; n = 11; 17 specimens).

Table 1 shows the baseline characteristics of the sample.

Surgical technique

Temporomandibular joint surgery was performed according to the technique described by Mehra and
Wolford 45.
First, the displaced disc is freed by the surgeon entering the upper and lower joint spaces and lysing
adhesions. At this point, a small hole is placed through the lateral pole of the condyle from posterior to
anterior direction. The Mitek bone‐cleat introducer is inserted and pushed into the bone, where two
small coils unlock and attach the cleat to the inner surface of the condyle cortical bone. A non‐
resorbable 2–0 or 3–0 suture is placed through the hole and through the disc at the junction of the
posterior and intermediate bands, and the disc is tied down to the condylar neck. The deformity of the
disc precludes repositioning it into a more normal position, and recontouring the thickened disc with a
scalpel is necessary (this scalpelled material constitutes the sample).
This procedure was conducted for all patients with disc displacement and the control group. In the CFx
patients, the disc displaced by fracture was repositioned and in the CH patients, the disc was sutured to
prevent disc displacement caused by the gap that was created after the high condylectomy. Post‐
surgical physical therapy was indicated at the discretion of the surgeon.
Histological sections obtained by scalpel of disc excess were prepared for observation of the in
situ expression of FasL by immunohistochemistry.

Immunohistochemistry

The TMJ disc sections were deparaffinized with xylol (2 × 10 min) and rehydrated with absolute ethylic
alcohol (3 × 1 min) and 80% ethylic alcohol (1 × 1 min). Endogenous peroxidase activity was quenched by
treatment with H2O2 (5% in methanol) for 10 min. Target Retrieval Solution™ (Dako, DK‐2600 Glostrup,
Denmark) was used prior to slide staining for heat‐inducing epitope retrieval (for formalin‐fixed,

paraffin‐embedded material), according to the manufacturer's instructions. The sections were incubated
with monoclonal FasL antibody (Novocastra, New Castle, UK), diluted 1:50 in phosphate‐buffered saline
(PBS), 0.1% bovine serum albumin (BSA). This monoclonal antibody immunostains only the cellular
fraction of FasL. The soluble fraction (sFasL), which is an inhibitor of the ligation between FasL and Fas in
the target cell, is not immunostained. For negative controls, the primary antibody was not added. PBS
was used instead. The secondary antibody, Advance™ (Dako, DK‐2600 Glostrup, Denmark), was applied
for 30 min, according to the manufacturer's instruction.
The immunoreactions were visualized by incubating the sections using 3,3′ diaminobenzidine (DAB)
chromogen (OriGene, Rockville, MD), (1 drop in 1 mL distilled water). The sections were lightly
counterstained with Harris haematoxylin for 5 min and finally mounted. Immunostaining was considered
to be specific to FasL because immunoreactivity was not observed in the negative controls.
The colour morphometry method was used to analyse the anti‐FasL‐immunostained area in the TMJ disc
tissue. For this purpose, images of consecutive fields were captured by the 40× objective lens coupled
with the BX50 Olympus microscope with the Sony camera, Model DXC‐107A, and image analysis was
performed with specific software called Image Pro Plus software (Media Cybernetics Inc., Silver Spring,
USA). This software allows an observer to select and paint the positive areas to obtain an image model
and make the mask for the other stained slides, being automatically calculated the area of the positive
reaction (Fig. 1). This procedure was performed by a single examiner in a blind manner. The data were
entered into a spread sheet, and Microsoft Excel (Redmond, WA, USA) was used to obtain the statistical
analysis. The variable area was measured in square micrometers (μm2) and was obtained with the mean
of all positive areas.

Figure 1. (A) Microphotography showing the positive immunohistochemical reaction for Fas ligand in brown, used
as the mask. (B) Image Pro Plus™ analysis of the positive immunohistochemical reaction identified by the software
through a sample of brown coloration considered appropriated by the observer, pattern followed for all fields
analysed. The mean of all positive reaction represented the immunohistochemical expression of FasL measured in
μm2.

Statistical analysis

To compare the groups regarding the area, the model of analysis of variance with one factor (anova)
was considered. To compare control and affected group, the Student's t‐test for independent samples or
nonparametric Mann–Whitney test was employed. To meet symmetrical condition of the variable, data
of area are previously submitted to a logarithmic transformation. P value <0.05 was considered
statistically significant. Data were analysed with the software Statistica V. 8.0 (StatSoft Inc., Tulsa, OK,
USA).

Results
Fas ligand expression was observed at cytoplasmic membrane, especially in fibrochondrocytes, and
statistically significant differences were found between TMJ samples of ADDwR and ADDwoR and
between TMJ discs of patients with and without osteoarthrosis.

Expression of FasL in TMJ sample ADDwR and ADDwoR

Significant differences were found in the expression of FasL in TMJ discs between the three groups for
the variable area (P = 0.001) (Table 2). However, it was observed significant difference only between
ADDwR and ADDwoR groups (P < 0.001) (Table 3, Figs 2 and 3), with higher area of expression in the
ADDwR (Table 2).
Table 2. FasL area of immunostaining (μm2) in the discs of the study group with and without TMJ
dysfunction
Variable
Área

•

Group
n
Mean Median
Control
8
15.17 15.44
ADDwR
17 22.91 19.85
ADDwoR 17 12.26 10.85
a
One‐factor anova, P < 0.05.

Minimum
7.64
11.21
5.97

Maximum
20.79
45.68
20.65

Standard deviation
4.08
11.50
4.43

P‐valuea
0.001

Table 3. Comparison 2 × 2 between groups with and without TMJ dysfunction with respect to area of
expression (μm2) of FasL
Groups
P‐valuea
Control × ADDwR
0.062
Control × ADDwoR 0.187
ADDwR × ADDwoR <0.001
•

a

Student's t‐test for independent samples, P < 0.05.

Figure 2. Immunostaining for Fas ligand in the temporomandibular joint disc of patients affected by disc
displacement with reduction (ADDwR). (A) Magnification of 10×. Arrow = fibrochondrocyte. (B) Magnification of
20×. Arrow = fibrochondrocyte.

Figure 3. Immunostaining for Fas ligand in the temporomandibular joint disc of patients affected by disc
displacement without reduction (ADDwoR). (A) Magnification of 10x. Arrow = fibrochondrocyte. (B) Magnification
of 20×. Arrow = fibrochondrocyte.

Expression of FasL in TMJ discs of patients with and without osteoarthrosis

It was observed that all the patients with ADDwoR presented OA. On the other hand, all patients
without OA presented ADDwR.
Statistically significant differences were found in the expression of FasL in TMJ discs between the groups
with and without OA for the variable area (P = 0.001) (Table 4).
Table 4. Differences between groups with and without osteoarthrosis with respect to area of in
situ expression (μm2) of FasL
Variable

Group

n

Mean

Median

Minimum

Maximum

Standard
deviation

P‐
valuea

FasL area
(μm2)

Without
osteoarthrosis

25

20.43

16.26

7.64

45.68

10.33

0.001a

With osteoarthrosis

17

12.26

10.85

5.97

20.65

4.43

•

a

Student's t‐test for independent samples, P < 0.05.

Discussion
Increasingly, studies have shown that mechanism of apoptosis plays an important role in the
progression of ID of the TMJ 22-28.
In diseases of the TMJ, the synovium and articular cartilage produce various mediators, such as IL‐1 and
FasL, that have the potential to induce chondrocyte death through necrosis or apoptosis 46-48. Some
studies showed correlation between TMJ ID and apoptosis mechanism. Imirzalioğlu et al. 28, in a study
using synovial fluid through arthrocentesis from 17 joints in 17 patients found lower levels of sFas,
suggesting vulnerability to apoptosis in patients with internal derangement. Increased levels of sFas
blocked apoptosis by inhibiting binding of FasL to Fas on the cell membrane 28. Immunohistochemical
studies with TMJ discs using some apoptosis markers found higher expression of caspase 3, TRAIL and
DR5‐positive cells in disc tissues in patients with ADDwR and ADDwoR than in control discs 22-27.
In this study, the analysis of FasL in TMJ discs of patients with and without disc displacement showed an
increased area of expression in fibrochondrocytes of the ADDwR group. Indeed, although physiologically
FasL is expressed by some cells as T lymphocytes or natural killer (NK) cells 49, our study shows FasL
expression by fibrochondrocytes. Biomechanical stress activates multiple parallel and converging signals
for hypertrophy and apoptosis 50. Considering the physiopathology of disc displacement, the
mechanical stress generated in jaw movement during the opening and closing of the mouth, which can
be stimulated by sliding the disc into and out of its normal position, prompts the activation of apoptosis
in these areas. Additionally, cartilage trauma may induce accelerated fibrochondrocyte apoptosis 50.
Thus, the higher expression of the marker FasL (CD95L) found in cases of ADDwR compared with
ADDwoR, in which a less intense inflammatory process and more mechanical stress may coexist, may

induce the apoptosis process. This phenomenon can set up an endogenous reaction, which aims to
restore homoeostasis and/or tissue remodelling. Therefore, the apoptotic event might work as a
protective mechanism to overcome progression of disease.
Osteoarthrosis is a focal degenerative disorder that primarily affects the articular cartilage and
subchondral bone of synovial joints such as TMJ 51-53. It is a consensus that TMJ disc displacement and
OA often occur concomitantly. The most frequently reported relationship is that disc displacement
causes OA 17, 50, 52-60. With physiological loading, there is a balance between synthesis and
breakdown within the tissue. When this adaptive capacity is exceeded, an inflammatory response may
become clinically evident and may result in damage to the cells, leading to cell destruction. Thus, in OA,
an inflammatory reaction reflects increased degenerative activity.
In this study, we investigated a possible association of FasL expression in TMJ discs with osteoarthrosis
process as the mechanism of apoptosis may influence the progression of ID. It was found an increase in
the expression of FasL in TMJ discs of individuals without OA. It worth mentioning that in our study, we
found a strong association between OA and ADDwoR, the most extreme phenotype, in which a greater
inflammatory process and minor mechanical stress coexist.
Our findings suggest that apoptosis process is a protective mechanism against TMJ disorder progression
and reinforce that necrosis should be the main way of cell death in OA fibrochondrocytes 61. Moreover,
considering that mechanical damage of articular cartilage is often associated with OA pathogenesis 61
and that fibrochondrocyte necrosis occurs in damage of articular cartilage, we can suggest that
apoptosis mechanism may precede necrosis on the TMJ ID. This might explain why there are some cases
in which the progression from ADDwR to ADDwoR might not occur and cases of patients with OA who
do not present TMJ problems.
Future studies should be performed with a larger sample size, which may make it clear the association of
a marker of apoptosis FasL with temporomandibular joint dysfunction. Although the sample number is
small, to the authors' knowledge, it is the largest sample reported in literature. Besides, the sample was
obtained from patients, and not from cadavers, as most study samples, which allows clinical
examination and anamnesis.
In conclusion, a higher expression of FasL was found in temporomandibular discs with reduction when
compared with discs without reduction. Moreover, a lower expression of FasL in the discs of patients
with osteoarthrosis was found, which suggests that apoptosis may protect against TMJ disorders
progression.
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